In 2013 Dr. Mats J. Olsson and ParkCell AB was in hard competition from many other companies and projects selected and awarded the BIO-X prize for “New opportunities for existing drugs”. This gives the company financial support from the Swedish Governmental Agency for Innovation Systems (VINNOVA).  The approved grants cover the project time April 2014 to April 2016.